Joint Formulary & PAD

Disopyramide - Arrhythmias

You are here : Home > Formulary Search > Disopyramide - Arrhythmias

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Capsules
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
SPC
Restrictions / Comments :
Important
Specialist initiation and at least one month supply before transfer to primary care
 

Status 2

Blue
Formulations :
  • Modified release tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
SPC
Restrictions / Comments :
Important
Specialist initiation and at least one month supply before transfer to primary care

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Disopyramide
Indication :
Arrhythmias
Group Name :
Keywords :
Brand Names Include :
Rythmodan
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
2

Committee Recommendations (1)

07 Aug 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.

Other Indications

Below are listed other indications that Disopyramide is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Arrhythmias.